• Publications
  • Influence
A case of transfusion‐transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food‐borne route
BACKGROUND: Five cases of transfusion transmission of hepatitis E virus (HEV) have been reported so far. The infection routes of the causative donors remain unclear, however. Also, the progress ofExpand
  • 260
  • 7
Independent Association Between Improvement of Nonalcoholic Fatty Liver Disease and Reduced Incidence of Type 2 Diabetes
OBJECTIVE Only a few studies have evaluated the long-term effects of nonalcoholic fatty liver disease (NAFLD) on type 2 diabetes mellitus (T2DM), and none have examined whether NAFLD improvementExpand
  • 102
  • 7
Effect of vitamin K2 on the recurrence of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is characterized by frequent recurrence, even after curative treatment. Vitamin K2, which has been reported to reduce HCC development, may be effective in preventingExpand
  • 87
  • 7
Three cases of acute or fulminant hepatitis E caused by ingestion of pork meat and entrails in Hokkaido, Japan: Zoonotic food‐borne transmission of hepatitis E virus and public health concerns
Aim:  In developed countries including Japan, the transmission route of indigenous hepatitis E virus (HEV) infection is obscure. Accordingly, public health implications of indigenous HEV infectionExpand
  • 61
  • 4
Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis
BackgroundHepatitis C virus (HCV) infection is a major comorbidity in patients receiving hemodialysis. Interferon-based antiviral therapy to eradicate HCV is less effective in patients receivingExpand
  • 71
  • 4
Role of hepatic resection in patients with intermediate‐stage hepatocellular carcinoma: A multicenter study from Japan
Transarterial chemoembolization (TACE) is recommended for patients with intermediate‐stage (Barcelona Clinic Liver Cancer criteria B [BCLC‐B]) hepatocellular carcinoma (HCC). However, patients withExpand
  • 22
  • 3
Clinical characteristics of Japanese patients with epithelioid hemangioendothelioma: a multicenter retrospective study
BackgroundEpithelioid hemangioendothelioma is an exceedingly rare sarcoma often occurring as an indolent angiocentric vascular tumor at various anatomic sites. Few reports have evaluated large caseExpand
  • 13
  • 3
Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis
Presently, there are no therapeutic options for unresectable hepatocellular carcinoma (u‐HCC) patients who are intolerant to sorafenib or regorafenib failure. There have been no reports with detailedExpand
  • 57
  • 2
Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis
We assessed suitable factors indicating newly developed lenvatinib (LEN) treatment for unresectable hepatocellular carcinoma (u‐HCC) by investigating real‐world clinical features of patients.
  • 40
  • 2
Feasibility of the virtual needle tracking system for percutaneous radiofrequency ablation of hepatocellular carcinoma
To evaluate the feasibility of the real‐time virtual needle tracking system for percutaneous radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC).
  • 23
  • 2